Lund OsteoArthritis Division - Molecular marker research group
21 – 30 of 180
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2024
-
Mark
From biochemical markers to molecular endotypes of osteoarthritis : a review on validated biomarkers
(
- Contribution to journal › Scientific review
-
Mark
Variations in trajectory of adherence to a digital self-management treatment for knee and hip osteoarthritis: predictors and consequences
(
- Contribution to journal › Published meeting abstract
-
Mark
Objective versus subjective function following a digitally delivered education and exercise therapy in people with knee or hip osteoarthritis
(
- Contribution to journal › Published meeting abstract
-
Mark
Serum ARGS-aggrecan in a phase 2 clinical trial targeting osteoarthritis
(
- Contribution to journal › Article
- 2023
-
Mark
Analysis of Rates of Completion, Delays, and Participant Recruitment in Randomized Clinical Trials in Surgery
(
- Contribution to journal › Article
-
Mark
Bariatric surgery, osteoarthritis and arthroplasty of the hip and knee in Swedish Obese Subjects – up to 31 years follow-up of a controlled intervention study
(
- Contribution to journal › Article
-
Mark
Digital self-management of hip and knee osteoarthritis and trajectories of work and activity impairments
(
- Contribution to journal › Article
-
Mark
Association of Traumatic Knee Injury With Radiographic Evidence of Knee Osteoarthritis in Military Officers
(
- Contribution to journal › Article
-
Mark
Incipient dementia and avoidable hospital admission in persons with osteoarthritis
(
- Contribution to journal › Article
-
Mark
Aggrecan accumulates at sites of increased pulmonary arterial pressure in idiopathic pulmonary arterial hypertension
(
- Contribution to journal › Article